Literature DB >> 18810550

Perceived vaccination status in ecotourists and risks of anthropozoonoses.

Michael P Muehlenbein1, Leigh Ann Martinez, Andrea A Lemke, Laurentius Ambu, Senthilvel Nathan, Sylvia Alsisto, Patrick Andau, Rosman Sakong.   

Abstract

Anthropozoonotic (human to nonhuman animal) transmission of infectious disease poses a significant threat to wildlife. A large proportion of travelers to tropical regions are not protected against vaccine-preventable illnesses, and a majority of these travelers demonstrate poor recall of actual vaccination status. Here we characterize self-perceived vaccination status among a large sample of ecotourists at the Sepilok Orangutan Rehabilitation Centre, Sabah, Malaysia. Despite their recognized travel itinerary to view endangered animals, tourists at wildlife sanctuaries are not adequately protected against vaccine-preventable illnesses. Of 633 surveys, over half reported being currently vaccinated against tuberculosis, hepatitis A, hepatitis B, polio, and measles. Fewer participants reported current vaccination status for influenza, rabies, and chickenpox. Despite the fact that the majority of visitors to Sepilok are from temperate regions where influenza is relatively more prevalent, 67.1% of those surveyed with medical-related occupations reported not being currently vaccinated for influenza. Ecotourists concerned about environmental protection are themselves largely unaware of their potential contribution to the spread of diseases to animals. The risks of negatively affecting animal populations must be communicated to all concerned parties, and this may begin by urging travelers to examine their actual vaccination status, particularly as the ecotourism industry continues its rapid expansion, and is seen increasingly as a possible tool to save great ape populations from extinction.

Entities:  

Mesh:

Year:  2008        PMID: 18810550     DOI: 10.1007/s10393-008-0192-y

Source DB:  PubMed          Journal:  Ecohealth        ISSN: 1612-9202            Impact factor:   3.184


  31 in total

1.  Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study.

Authors:  Koen Van Herck; Jane Zuckerman; Francesco Castelli; Pierre Van Damme; Eric Walker; Robert Steffen
Journal:  J Travel Med       Date:  2003 Mar-Apr       Impact factor: 8.490

2.  Status of immunity to tetanus, measles, mumps, rubella, and polio among U.S. travelers.

Authors:  E Hilton; C Singer; P Kozarsky; M A Smith; M P Lardis; M T Borenstein
Journal:  Ann Intern Med       Date:  1991-07-01       Impact factor: 25.391

Review 3.  Vaccines in travel health: from risk assessment to priorities.

Authors:  Robert Steffen; Bradley A Connor
Journal:  J Travel Med       Date:  2005 Jan-Feb       Impact factor: 8.490

4.  [Vaccination status of French and European travelers: a study of 9,156 subjects departing from Paris to 12 tropical destinations].

Authors:  T Prazuck; C Semaille; M Defayolle; P Bargain; M Clerel; C Lafaix; A Santin; A Fisch
Journal:  Rev Epidemiol Sante Publique       Date:  1998-02       Impact factor: 1.019

5.  Anthropozoonotic Giardia duodenalis genotype (assemblage) a infections in habitats of free-ranging human-habituated gorillas, Uganda.

Authors:  Thaddeus K Graczyk; John Bosco-Nizeyi; B Ssebide; R C Andrew Thompson; Carolyn Read; Michael R Cranfield
Journal:  J Parasitol       Date:  2002-10       Impact factor: 1.276

Review 6.  Yellow fever: an update.

Authors:  T P Monath
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

7.  A single genotype of Encephalitozoon intestinalis infects free-ranging gorillas and people sharing their habitats in Uganda.

Authors:  Thaddeus K Graczyk; John Bosco-Nizeyi; Alexandre J da Silva; Iaci N S Moura; Norman J Pieniazek; Michael R Cranfield; H D Alan Lindquist
Journal:  Parasitol Res       Date:  2002-06-28       Impact factor: 2.289

8.  Travelers' knowledge, attitudes and practices on the prevention of infectious diseases: results from a study at Johannesburg International Airport.

Authors:  Stephen Toovey; Andrew Jamieson; Michele Holloway
Journal:  J Travel Med       Date:  2004 Jan-Feb       Impact factor: 8.490

9.  Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey.

Authors:  Koen Van Herck; Pierre Van Damme; Francesco Castelli; Jane Zuckerman; Hans Nothdurft; Atti-La Dahlgren; Sandra Gisler; Robert Steffen; Panagiotis Gargalianos; Rogelio Lopéz-Vélez; David Overbosch; Eric Caumes; Eric Walker
Journal:  J Travel Med       Date:  2004 Jan-Feb       Impact factor: 8.490

10.  Assessment of an Adult Population's Knowledge Regarding Vaccine-Preventable Diseases.

Authors: 
Journal:  J Travel Med       Date:  1996-06-01       Impact factor: 8.490

View more
  5 in total

1.  Consequences of non-intervention for infectious disease in African great apes.

Authors:  Sadie J Ryan; Peter D Walsh
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

2.  Ape conservation physiology: fecal glucocorticoid responses in wild Pongo pygmaeus morio following human visitation.

Authors:  Michael P Muehlenbein; Marc Ancrenaz; Rosman Sakong; Laurentius Ambu; Sean Prall; Grace Fuller; Mary Ann Raghanti
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

3.  Lack of Rule-Adherence During Mountain Gorilla Tourism Encounters in Bwindi Impenetrable National Park, Uganda, Places Gorillas at Risk From Human Disease.

Authors:  Annalisa Weber; Gladys Kalema-Zikusoka; Nancy J Stevens
Journal:  Front Public Health       Date:  2020-02-13

Review 4.  Potential Pathogens Reported in Species of the Family Viverridae and Their Implications for Human and Animal Health.

Authors:  L V Wicker; P J Canfield; D P Higgins
Journal:  Zoonoses Public Health       Date:  2016-06-30       Impact factor: 2.702

5.  Vaccines in a hurry.

Authors:  Christian Søborg; Kåre Mølbak; T Mark Doherty; Peter Ulleryd; Tim Brooks; Claudine Coenen; Ben van der Zeijst
Journal:  Vaccine       Date:  2009-02-20       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.